Overview
At MedGenome, we provide a wide range of advanced testing solutions to support the diagnosis and management of cancers, including both blood cancers (haematological malignancies) and solid tumours. Our goal is to help clinicians make more informed decisions at every stage of the cancer care journey. From understanding the type and stage of cancer to selecting the most suitable treatment and monitoring how the disease responds, our tests are designed to offer clear and reliable insights. By combining genetic and molecular testing with clinical expertise, we aim to improve how cancer is diagnosed, treated, and monitored, leading to better outcomes for patients.
Minimally Invasive Early Cancer Detection Test
Revolutionising Early Cancer Detection

Advanced Genetic Testing for Better Diagnosis, Treatment, and Monitoring of Leukemia

Advanced Genetic Testing for Cancer Treatment

India’s First Genome-Wide Methylation-Based Precision Diagnostic Test for CNS Tumors
Advanced Genetic Testing for Personalised Cancer Treatment

Identifying Key Cancer Causing Mutations for Targeted Therapy

Comprehensive Diagnostic and Risk Stratification Solutions for Plasma Cell Disorders

Comprehensive Thyroid Tumour Testing

Detecting Mutations & Enhancing Targeted Cancer Treatment

Precision Testing for Targeted GIST Treatment

Detecting Resistance Mutations for Personalised Cancer Treatment
Enhanced for deeper tumor insights — a single, multi-biomarker, tumor-agnostic tissue genomic test
Largest CAP-Accredited and NABL-Certified Genomics Sequencing Lab in South Asia
Largest CAP-Accredited and NABL-Certified Genomics Sequencing Lab in South Asia
5,00,000+ Exomes and Genomes Sequenced
Trusted by the Scientific Community, Over 1,000+ Research Citations and Counting
1,300+ Genetic Tests Across Various Disease Categories
1300+ Employees, 160+ Scientists, 150+ Genome Analysts & 70+ Bioinformatics Engineers
Delivering Excellence in 600+ Locations Pan India and Across 40 Countries.

Connect with Our Experts